NCT03373591View on ClinicalTrials.gov

Liposomal Bupivacaine in Bariatric Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

219

Participants

Timeline

Start Date

January 30, 2018

Primary Completion Date

June 30, 2018

Study Completion Date

December 31, 2018

Conditions
Bariatric Surgery Analgesia
Interventions
DRUG

Liposomal Bupivacaine TAP block

Infiltration of the transverse abdominis peritoneum by a local anesthetic under laparoscopic visualization.

DRUG

Bupivacaine TAP block

Infiltration of the transverse abdominis peritoneum by a local anesthetic under laparoscopic visualization.

Trial Locations (1)

10467

Montefiore Medical Center, The Bronx

All Listed Sponsors
lead

Montefiore Medical Center

OTHER

NCT03373591 - Liposomal Bupivacaine in Bariatric Surgery | Biotech Hunter | Biotech Hunter